Evidence map›Paper›PMID 12027802›Full record

ArticleThe Biochemical journal2002

Down-regulation of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by insulin: the role of the forkhead transcription factor FKHRL1.

Alícia Nadal, Pedro F Marrero, Diego Haro

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. PTEN: Tumor Suppressor and Metabolic Regulator.Frontiers in endocrinology · 2018
    Review
  9. Article
  10. Regulation of Ketone Body Metabolism and the Role of PPARα.International journal of molecular sciences · 2016
    Review
  11. Article
  12. Article
  13. Decrease in mitochondrial function in rat cardiac permeabilized fibers correlates with the aging phenotype.The journals of gerontology. Series A, Biological sciences and medical sciences · 2010
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alícia NadalDepartment of Biochemistry and Molecular Biology, School of Pharmacy, University of Barcelona, Avda. Diagonal, 643, E-08028 Barcelona, Spain.
Pedro F Marrero
Diego Haro
Universitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Normal physiological responses to carbohydrate shortages cause the liver to increase the production of ketone bodies from the acetyl-CoA generated from fatty acid oxidation. This allows the use of ketone bodies for energy, thereby preserving the limited glucose for use by the brain. This adaptative response is switched off by insulin rapidly inhibiting the expression of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (HMGCS2) gene, which is a key control site of ketogenesis. We decided to investigate the molecular mechanism of this inhibition. In the present study, we show that FKHRL1, a member of the forkhead in rhabdosarcoma (FKHR) subclass of the Fox family of transcription factors, stimulates transcription from transfected 3-hydroxy-3-methylglutaryl-CoA synthase promoter-luciferase reporter constructs, and that this stimulation is repressed by insulin. An FKHRL1-responsive sequence AAAAATA, located 211 bp upstream of the HMGCS2 gene transcription start site, was identified by deletion analysis. It binds FKHRL1 in vivo and in vitro and confers FKHRL1 responsiveness on homologous and heterologous promoters. If it is mutated, it partially blocks the effect of insulin in HepG2 cells, both in the absence and presence of overexpressed FKHRL1. These results suggest that FKHRL1 contributes to the regulation of HMGCS2 gene expression by insulin.

Indexed as

Down-RegulationNerve Tissue ProteinsProtein Serine-Threonine KinasesAndrostadienesAnimalsChromatinChromonesDNA-Binding ProteinsDNA, MitochondrialEnzyme InhibitorsFatty AcidsForkhead Box Protein O1Forkhead Box Protein O3Forkhead Transcription FactorsGenes, ReporterHepatocytes2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAndrostadienesChromatinChromonesDNA-Binding ProteinsDNA, MitochondrialEnzyme InhibitorsFatty AcidsForkhead Box Protein O1Forkhead Box Protein O3Forkhead Transcription FactorsFOXO1 protein, humanFoxo1 protein, ratFOXO3 protein, humanFOXO3 protein, ratHydroxymethylglutaryl-CoA SynthaseInsulinLuciferasesMorpholinesNerve Tissue ProteinsPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktTranscription FactorsWortmannin

Identifiers

PMID12027802
PMCPMC1222772
OpenAlexW20311902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.